Just curious if there’s any indication if this new drug will succeed Abiraterone and Xtandi?
Thanks,
Elisa
Just curious if there’s any indication if this new drug will succeed Abiraterone and Xtandi?
Thanks,
Elisa
It's still recruiting.
Opevesostat (MK-5684, ODM-208) is an investigational drug being developed for metastatic castration-resistant prostate cancer (mCRPC) that inhibits CYP11A1, a key enzyme in steroid hormone production, potentially suppressing androgen receptor signaling and cancer progression.
to Lavender22: This is in your husband's bio (very similar to mine).
'Wife of a nice guy with advanced prostate cancer'.
Mine: 'Wife and Girlfriend(s) of a nice guy with advance prostate cancer".
Now if you don't mind could add a little more info to your nice guy's bio. Thank you!!!
Good Luck, Good Health and Good Humor.
j-o-h-n